Education

Immunosuppressant and Antiretroviral Drug Interaction Management in HIV Infected Transplant Recipients

Tuesday, March 30, 2010

In this podcast, Dr. Gregory E. Malat, Transplant Pharmacist Hahnemann University Hospital and Assistant Professor Drexel University School of Medicine, and Dr. Eric M Tichy, Clinical Pharmacist from the Yale-New Haven Transplantation Center, discuss the unique issues regarding management of drug interactions between transplant immunosuppressants and highly active antiretroviral therapy (HAART). Dr. Malat describes the components of HAART regimens, reviews the impact HAART medications have on immunosuppressant drug levels, and provides recommendations for management of these issues in the clinical transplant setting.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.